一例新冠肺炎合并气管支气管曲霉菌病的病例报告
A Case Report of COVID-19 With Tracheobronchial Aspergillosis.
作者信息
Liu Haolei, Jiao Hailu, Feng Jun, Gao Hui, Wu Shikui
机构信息
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.
Key Laboratory of Traditional Chinese Medicine for Lung Diseases, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.
出版信息
Case Rep Infect Dis. 2025 Apr 13;2025:4627040. doi: 10.1155/crdi/4627040. eCollection 2025.
The concurrence of COVID-19 and tracheobronchial aspergillosis (TBA) is rarely documented in clinical practice. This report presents a case of TBA in a patient diagnosed with COVID-19 prior to the administration of immunosuppressive agents. This case underscores the necessity of considering fungal infections in patients with COVID-19, even during the early stages of the disease. The combination of timely bronchoscopy, antiviral therapy, and antifungal treatment resulted in favorable therapeutic outcomes for the patient.
新型冠状病毒肺炎（COVID-19）与气管支气管曲霉病（TBA）并存的情况在临床实践中鲜有记录。本报告介绍了一例在使用免疫抑制剂之前被诊断为COVID-19的患者发生TBA的病例。该病例强调了即使在COVID-19疾病的早期阶段，也有必要考虑对患者进行真菌感染的评估。及时进行支气管镜检查、抗病毒治疗和抗真菌治疗相结合，为该患者带来了良好的治疗效果。
Zotero 插件